Parkinson's Disease
Parkinson's Disease
Parkinson’s disease strikes 2 in every 1,000 people, most often developing in those older than age 50. Because of increased longevity, this amounts to roughly 60,000 new cases diagnosed annually in the United States alone.
Most recent articles
Genetic Insights into Early-onset Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, affecting up to 1.5% of the American population.1 It...
Recognising Early Symptoms of Alzheimer’s Disease in Routine Clinical Practice
In the EU, more than seven million people are estimated to have dementia.1 An ageing population will lead to an increase in dementia cases,1 with...
Rotigotine for the Treatment of Advanced Parkinson’s Disease
Parkinson’s disease (PD) is a progressive neurodegenerative condition1 affecting over 1 million people in Europe2 and North America.3 A systematic...
The Effect of Non-motor Symptoms on Quality of Life in Parkinson’s Disease
Parkinson’s disease (PD) affects about 1–2% of the population over 65 years of age and up to 3–5% of people 85 years of age and older.1 As the...
Imaging, Cognition, and Parkinson’s Disease—An Overview
Parkinson’s disease (PD) is characterized by motor symptoms including resting tremor, rigidity, and bradykinesia. However, cognitive and behavioral...
Medical Guidelines
To provide a user-friendly, clinical evidence-based guideline for the National Health Service (NHS) in England and Wales that:...
DISEASE/CONDITION(S) Alzheimer disease Dementia Other chronic dementing illnesses (e.g., Pick's disease, Huntington disease, and Parkinson disease) GUIDELINE CATEGORY Management CLINICAL SPECIALTY...
